Literature DB >> 9648159

Extrauterine low-grade endometrial stromal sarcoma: report of three cases.

M Fukunaga1, A Ishihara, S Ushigome.   

Abstract

Three cases of rare low-grade endometrial stromal sarcoma of the extrauterine tissue are presented. Each one occurred in the ovary, pelvic and abdominal cavities. Two were associated with endometriosis. Histologically, the tumors were characterized by an infiltrative and diffuse proliferation of uniform round or oval cells, abundant small vessels, low mitotic activity, the presence of foam cells and vascular invasion. Immunohistochemically, all tumors expressed vimentin, muscle markers (desmin, muscle-specific actin and alpha-smooth muscle actin) and progesterone receptors. Two tumors were diploid and one was aneuploid by flow cytometry. All patients were well with no evidence of disease 16-39 months after surgery. It is suggested that this neoplasm may arise with or without endometriosis under hormonal influence. This rare variant of Müllerian tumors should not be confused with adenosarcoma and soft tissue tumors, such as smooth muscle tumors and solitary fibrous tumor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9648159     DOI: 10.1111/j.1440-1827.1998.tb03909.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  10 in total

1.  Cannonball metastases with favourable prognosis.

Authors:  R Flavin; S Finn; A McErlean; P Smyth; J Meaney; F O'Connell; J Kellett; E McGovern; E Gaffney
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

2.  Endometrial stromal sarcoma presenting as prevesical mass mimicking urachal tumor.

Authors:  Seung Il Jung; Sang Soo Shin; Chan Choi; Eu Chang Hwang; Sun-Ouck Kim; Taek Won Kang
Journal:  J Korean Med Sci       Date:  2009-06-16       Impact factor: 2.153

3.  Undifferentiated Endometrial Sarcoma of the Ovary: A Case Report with Review of Recent Literature and Discussion of Lacking Specificity of CD10 Immunoreactivity.

Authors:  Hermann Brustmann; Ingrid M Geiss; Susanne Hinterholzer
Journal:  Patholog Res Int       Date:  2009-10-21

Review 4.  Cervical Mullerian adenosarcoma with heterologous sarcomatous overgrowth: a fourth case and review of literature.

Authors:  Tito Silvio Patrelli; Salvatore Gizzo; Stefania Di Gangi; Giorgia Guidi; Mario Rondinelli; Giovanni Battista Nardelli
Journal:  BMC Cancer       Date:  2011-06-11       Impact factor: 4.430

5.  Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas.

Authors:  O Reich; S Regauer; W Urdl; M Lahousen; R Winter
Journal:  Br J Cancer       Date:  2000-03       Impact factor: 7.640

6.  Primary endometrioid stromal sarcomas of the ovary: a clinicopathological study of 14 cases with a review of the literature.

Authors:  Weimin Xie; Xiaoning Bi; Dongyan Cao; Jiaxin Yang; Keng Shen; Yan You
Journal:  Oncotarget       Date:  2017-06-28

Review 7.  Primary extragenital endometrial stromal sarcoma of the lung: first reported case and review of literature.

Authors:  Lara Alessandrini; Francesco Sopracordevole; Giulio Bertola; Simona Scalone; Martina Urbani; Gianmaria Miolo; Tiziana Perin; Fabrizio Italia; Vincenzo Canzonieri
Journal:  Diagn Pathol       Date:  2017-05-02       Impact factor: 2.644

8.  An unexpected diagnosis of primary omental endometrial stromal sarcoma in a patient with acute right abdominal pain: A case report and review of literature.

Authors:  Vered Buchholz; George Kiroff; Markus Trochsler; Harsh Kanhere
Journal:  Int J Surg Case Rep       Date:  2017-04-19

9.  Extra-uterine low grade endometrioid stromal sarcoma arising from ovarian endometriosis: a case report and review of the literature.

Authors:  Boubacar Efared; Ibrahim S Sidibé; Fatimazahra Erregad; Nawal Hammas; Laila Chbani; Hinde El Fatemi
Journal:  Gynecol Oncol Res Pract       Date:  2019-01-29

10.  Primary sarcoma of the cervix: an analysis of patient and tumor characteristics, treatment patterns, and outcomes.

Authors:  Ashley Albert; Anna Lee; Robert Allbright; Srinivasan Vijayakumar
Journal:  J Gynecol Oncol       Date:  2019-10-23       Impact factor: 4.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.